Sunitinib malate gastrointestinal stromal tumour - PBS authority application form (PB096)

Use this form for a patient starting initial PBS subsidised treatment with sunitinib malate for metastatic or unresectable malignant gastrointestinal stromal tumour after failure of imatinib mesylate treatment due to resistance or intolerance.

PBS is the Pharmaceutical Benefits Scheme.

This form can be uploaded through HPOS. Read more about form upload in HPOS.
This PDF is fillable. Download this form and complete it on your device, or print it and complete it by hand.

Page last updated: 14 November 2018